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SUMMARY 
Examples suggesting that all or part of the VH segment of a rearranged VHDJH 
may be replaced by all or part of another VH have been appearing since the 1980s. 
Evidence has been presented of two rather different types of replacement. One of 
these has gained acceptance and has now been clearly demonstrated to occur. The 
other, proposed more recently, has not yet gained general acceptance because the 
same effect can be produced by PCR artefact. We review both types of 
replacement including a critical examination of evidence for the latter. The first 
type involves RAG proteins and recombination signal sequences (RSS) and occurs 
in immature B cells. The second was also thought to be brought about by RAG 
proteins and RSS. However, it has been reported in hypermutating cells which are 
not thought to express RAG proteins but in which AID has recently been shown to 
initiate homologous recombination. Re-examination of the published sequences 
reveals AID target sites in VH-VH junction regions and examples that resemble 
gene conversion. 
 
INTRODUCTION 
Faced with selective pressure to change the specificity of a rearranged immunoglobulin 
gene, (or rescue itself from two non-functional rearrangements) a B cell may make a 
secondary rearrangement on the same chromosome1-4. Some authors divide this into 
‘receptor editing’ when it occurs centrally (in the bone marrow), and ‘receptor revision’ 
when it occurs in the periphery (in germinal centres) the former thought to be largely 
tolerance-driven and the latter mainly diversity-driven. Most rearranged light-chain 
genes will have both unrearranged VL gene segments upstream and unrearranged JL 
segments downstream, so it is possible for an upstream VL segment to recombine with a 
downstream JL segment to form a new VLJL exon with deletion of the original 
rearrangement. At the heavy-chain locus the situation is different because the rearranged 
gene contains a D segment and in humans all the unused D segments are deleted during 
the D-JH and VH-DJH rearrangements. Several possible varieties of secondary 
rearrangement at the heavy chain locus have been suggested, but the ones for which 
there are the most evidence are replacement of all or part of the primarily rearranged VH 
segment by all or part of an upstream VH gene segment, and these comprise the subject 
of this article. 
Two quite different mechanisms of VH replacement have been reported. We refer to 
these as Types 1 and 2. We review the evidence for both types of replacement, describe 
examples of confusion between the two, and consider what is the most likely 
explanation for the Type 2 sequences in the light of other recent findings and our own 
re-examination of the sequences. We begin with a summary of current understanding of 
primary V(D)J recombination. 
 
V(D)J REARRANGEMENT AND NON-HOMOLOGOUS END JOINING 
V(D)J recombination takes place in two stages. The first, recognition and cleavage of 
specific sequences within the Ig loci, is unique to V(D)J recombination. The second, the 
processing and joining of the cleaved ends, involves components of the ubiquitous non-
homologous end-joining (NHEJ) system. Understanding of the details of primary V(D)J 
rearrangement is developing rapidly5-9. The functional V, D and J gene segments have 
recombination signal sequences (RSS), each consisting of a specific heptamer and 
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nonamer separated by a spacer of 12 bp (roughly one turn of the DNA helix) or 23 bp 
(roughly two DNA turns). These distances are important for protein binding, and most 
efficient cleavage and rejoining occurs when one of each type of RSS are brought 
together in a protein complex. This ensures recombination of the correct coding 
sequences to make a functional product since, at the heavy-chain locus, the V and J 
segments all have RSS with a 23 bp spacer and the D segments have 12 bp spacers on 
both ends. The heptamer sequences are immediately adjacent to the ends of the coding 
sequences that are to be joined and have the same consensus sequence but are in 
opposite orientations. The sequence of the heptamer is more critical than that of the 
nonamer and the most important sequence is the three bases next to the cleavage point, 
CAC on the sense strand in RSS at the 3' ends of coding segments, GTG in those at the 
5' ends10. A complex formed by the products of the ‘recombination activating genes’, 
RAG-1 and RAG-2, and the high mobility group 1 (HMG1) protein binds the RSS and 
nicks the DNA precisely at the interfaces between the coding sequences and the RSS. 
The free –OH group on the 3' end of the coding sequence at each nick then attacks the 
opposite DNA strand and the result is a closed hairpin loop on each coding sequence 
end and a blunt double-strand break at the end of each RSS. 
The ends are then joined by NHEJ, present in all cells for repair of double-stranded 
DNA breaks. It frequently uses very short sequence-matches of typically 1 - 4 bp near 
the ends to be joined and frequently involves removal of nucleotides from the ends. In 
V(D)J recombination this imprecision is a benefit, conferring extra diversity to 
antibodies. 
The proteins of the NHEJ system involved in V(D)J recombination include the 
Ku70-Ku86 heterodimer, Artemis, DNA-dependent protein kinase catalytic subunit, 
XRCC4 (X-ray cross-complementation group 4), DNA ligase IV, and others yet to be 
identified5-7,11. The cleaved ends bearing RSS are usually ligated together (signal-to-
signal joint) by perfect blunt-ended ligation without loss or addition of bases. At the 
coding ends, the hairpins are opened by nicking and, if not central, this results in 
addition of palindromic (P) nucleotides. However, there is often excision of several 
nucleotides. Before joining there is usually nontemplated (N) addition of nucleotides to 
the 3' ends by terminal deoxynucleotidyl transferase (TdT). Complementary matches of 
one or a few bases at or near the ends of these extensions may then be used to pair the 
ends, non-matching bases are removed, gaps are filled in and nicks ligated. Where the 
coding segments joined are in the same orientation, as in the unrearranged human 
heavy-chain locus, ligation of the RSS causes the exclusion of the intervening DNA 
from the chromosome as a closed loop. Presentation of a functional B-cell receptor on 
the cell surface leads to down-regulation of the RAG genes, preventing further V(D)J 
rearrangement. It has yet to be established for certain whether RAG genes can be 
reactivated in mature cells in vivo or whether RAG-mediated secondary rearrangement 
only occurs in immature cells12. However, it has been shown that RAG expression and 
receptor revision can be induced in mature B cells in vitro13. 
 
TYPE 1 VH REPLACEMENT 
Type 1 VH replacement is essentially the same mechanism as primary V(D)J 
rearrangement, using legitimate or ‘cryptic’ RSS in opposite orientations, usually 
involving deletion from the cleaved coding ends, addition of P and N nucleotides at the 
new junction, and sometimes a substantial change in length. It also frequently causes a 
change in frame, making a non-functional product from a functional one, or vice-versa. 
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Because the D segment of the rearranged VH-D-JH exon no longer has its own 5' 
RSS, cryptic RSS within the VH are always involved in Type 1 VH replacement. There 
are variations between RSS of different gene segments in the heptamer, spacer, and 
nonamer sequences10,14 but the consensus sequence of the heptamer on the 5' ends of the 
D segments is CACTGTG. Close to the 3' end of nearly all of the functional human and 
mouse VH segments is the sequence TACTGTG, only one base different from the 
consensus heptamer, and this can act as a surrogate for the original RSS on the 5' end of 
the D segment15. Within most VH segments there are also more proximal cryptic RSS in 
both orientations, not as close to the RSS consensus as the 3' cryptic RSS. These appear 
to be used very rarely in Type 1 replacement. Separated by 12 bases upstream from the 
3' cryptic heptamer (also known as ‘the internal heptamer’) is a nonamer sequence that 
varies a little between VH genes. It does not resemble the consensus nonamer of the real 
RSS but, because of its conservation, Chen et al.16 considered that it might act as a 
signal sequence. Nadel et al.17 did not detect recombination in pre-B cells transfected 
with plasmids containing the complete nonamer-spacer-heptamer ‘embedded RSS’ 
present in the 3' end of several of the mouse VH genes, and concluded that VH 
replacement must be an infrequent event, unlikely to contribute significantly to receptor 
editing. However, numerous examples of VH replacement continued to be observed in 
pre-B-cell lines (endogenous genes and introduced substrates), lymphomas and 
leukaemias15,18-29, and in transgenic mice16,30,31. 
The reported Type 1 VH replacements fall into three subtypes. (i) As in the references 
above, a complete upstream VH segment may be recombined into a rearranged VH-D-JH 
through the agency of its own RSS and the 3' cryptic RSS of the rearranged VH (Fig. 
1a). This effectively increases the length of the VH-D junction and has a (theoretically 
⅓) chance of producing a functional heavy chain (depending on the reading frame). 
Most examples of Type 1 VH replacement recorded so far are of this subtype. (ii) A 
complete VH gene segment may be recombined into the VH-D-JH with its own RSS and 
a more 5' cryptic RSS in the already-combined VH (Fig. 1b). In the one example to 
date32, the incoming VH was in a different frame from the original and this resulted in a 
stop codon being read in the original VH. The nearest possible cryptic RSS 5' of the 
cleavage point in the original VH (now known as VH3-49) is TATGGTG in codons 53 – 
55. Only the four bases underlined are shared in common with the consensus RSS, 
which may explain why this is a rare event. (iii) Cryptic RSS in opposite orientations 
and different positions within both VH might be involved (Fig. 1c). However, we have 
now shown (unpublished observation) that the three published examples33 result from a 
duplication within one VH. 
Other types of RAG-mediated rearrangement, D→VHDJH and V→D→VHDJH may 
occur in artificial systems16,34. Taki et al.34 found that of 53 RSS-like motifs present in 
the monoclonal mouse system that they were using, only two were used, suggesting that 
other sequences are involved in the targeting of RAG-mediated recombination in 
addition to the RSS. 
The sequence between the 3' cryptic RSS and the 3' end of the VH is 5 – 9 (usually 7) 
bases long in human VH genes. This may be truncated from its 3' end in the original 
rearrangement and from its 5' end after the 3' cryptic RSS is cleaved off. Therefore the 
VH-D junction, after Type 1(i) VH replacement, will usually be longer than the original 
VH-D junction with the same sequence towards its 3' end, new sequence at its 5' end, 
and possibly a remnant of the tail of the original VH in the middle, as shown in Fig. 2(a). 
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This is easy to identify by comparing sequences from members of the same B-cell clone 
but almost impossible to identify in isolation. 
Recently, Zhang et al.35 demonstrated Type I VH replacement conclusively in an 
acute lymphocytic leukaemia cell-line that undergoes continuous pro-B to pre-B to B-
cell differentiation and serial VH replacement. Different members of the cell line 
contained rearranged genes with the same D-JH junction but different VH segments, and 
remnants of previous VH segments in some of the VH-D junctions. The investigators 
demonstrated double-strand DNA breaks at 3' cryptic RSS, VH-replacement excision 
circles, binding of co-purified recombinant RAG1/RAG2 to cryptic RSS, nicking at the 
heptamer ends, and coding-end hairpin formation. Furthermore, they found that the 3' 
cryptic heptamer enhanced hairpin formation with true RSS with both 12 bp and 23 bp 
spacers. They also found evidence for Type 1 VH replacement in healthy human 
neonates and adults. A search of the V-D junctions of 343 functional IgH sequences 
from 18 subjects identified 16 (~5%) with 5 consecutive matches to a 3' VH sequence. 
When they lowered the stringency to 6 bases with one mismatch, this increased to 
~12%, and the true frequency of Type I replacement is likely to be much higher, 
because, as we mentioned earlier, there will frequently be little or no trace of the 
previous VH segment. 
 
TYPE 2 VH REPLACEMENT 
Type 2 VH replacement has been described much more recently than Type 136-38. The 
result gives the appearance of homologous recombination between two VH gene 
segments (Fig. 2b). Because the exchange occurs in a stretch in which both segments 
have the same sequence, the exact point of exchange cannot be determined for certain; it 
is only delimited by the closest positions of difference between the two sequences in 
either direction. It has been proposed to occur at cryptic RSS but the recombination 
process is quite different from normal V(D)J rearrangement because the supposed 
cryptic RSS are in the same orientation, one of them remains in the recombined product, 
there is no addition of nucleotides at the point of exchange, and (with a single 
exception36) no nucleotides are deleted from the gene sequence. The specificity of the 
antibody is changed, the reading frame of the gene is unchanged and the VH-D junction 
is always unchanged. If this type of VH replacement is guided by cryptic RSS, the joints 
formed must be signal-to-coding joints, known as hybrid joints. These have been shown 
to occur but, when they do, there is usually deletion of nucleotides from the coding end 
and addition of new nucleotides39. 
During PCR amplification of DNA prepared from many lymphocytes, it is possible 
for the reaction to produce a rearranged VH-D-JH sequence with a hybrid VH just like the 
postulated Type 2 replacement (Fig. 3). Double strand breaks (DSBs), targeted to 
RGYW·WRCY motifs have been found to occur in unrearranged V gene segments and 
in rearranged genes in the absence of AID, a protein essential for hypermutation40-42. On 
AID expression, additional staggered breaks occur at the same target43. All these breaks 
will result in incomplete single-strand PCR products, ripe for hybrid artefact formation, 
whose likelihood may thus be increased in mutating cells. It is therefore necessary to 
establish that Type 2 replacements occur in vivo. 
Wilson et al.36 examined sequences from purified IgD+IgM-CD38+ tonsil B cells. In 
one group of 65 clonally related sequences (with the same CDR3) there were 7 that all 
had the same partial VH replacement but differed in their mutations. In a phylogeny of 
the complete sequences these hybrids would be bound to come together on the tree, but 
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these sequences all came on the same branch of a phylogenetic tree based only on the 
unreplaced segment, strongly suggesting that a single replacement event occurred, 
followed by further somatic mutation. There are at least three ways that this appearance 
might be produced by PCR artefact. Firstly, a single PCR hybridisation could have 
occurred, followed by polymerase errors in some of the copies. These sequences would 
come together on the tree because they only differed by a single nucleotide. Experience 
in our laboratory has shown that even with a high-fidelity polymerase system this can 
happen when many copies of the same template are cloned and sequenced (error 
frequency ~1/1200 bp in nested PCR or ~1·1 × 10-5/changes/bp/cycle44). Discounting 
this, one might postulate that 7 separate PCR hybridsations had occurred between the 
same regions of copies of the same two rearranged genes but these would have to have 
mutation patterns so similar that the products came together on the tree despite the 
presence of many differently-mutated copies of these genes (and many other rearranged 
templates) in the reaction. The chance of this seems negligible. In another group of 77 
clonally related sequences there were two with the same Type 2 VH replacement and 
they also came side-by-side on their phylogenetic tree, apparently compounding the 
likelihood that this was in vivo recombination. 
There is, however, another possibility. If, after the first PCR hybridisation, further 
hybridisation occurred not to native templates but to the hybrid template, these 
secondary hybridisations would be much more likely to occur with sequences having 
closely related patterns of mutation. On both trees there were nonhybrid sequences 
beyond hybrid ones on the same branch. This is clearly impossible. The trees were 
produced by parsimony, and the findings might be a demonstration of the inadequacy of 
parsimony alone in constructing phylogenetic trees, or due to use of incomplete 
sequences, but it could also be an indication that the results were artefactual. The 
investigators36 took the presence of somatic mutations before as well as after the 
replacements to indicate that replacement must have taken place in the periphery, i.e. 
that they were examples of receptor revision, and this must surely be the case if their 
explanation is correct. 
Four more hybrid VH genes were found in the two clones already mentioned, and a 
further ten amongst >700 sequences from different B-cell subsets from tonsils of four 
other individuals, but they were all single examples of partial VH replacements and so 
could not be distinguished from PCR artefacts. However, cryptic RSS were found in all 
nine different cross-over regions in the fifteen different examples of VH exchange. As 
some of these regions were quite long (up to at least 43 bp) and some of the identified 
cryptic RSS were only CAC or GTG, there was a high probability of some of these 
being present by chance, but the presence of an RSS in all nine regions cannot be 
ignored. 
The VH in a rearranged VHDJH can only be replaced by a VH upstream on the same 
chromosome, because the downstream VH segments have all been deleted in the original 
rearrangement, but in 8/15 of the hybrids the incoming VH was downstream in the 
existing VH locus maps, which again could indicate PCR artefact. The authors 
considered the most likely possibility to be that mapping of the VH region of more 
individuals will reveal more differences in order since the only two complete maps 
differ considerably. Less likely, they considered, was the possibility that the incoming 
VH sequence had come from the other chromosome. Zhang et al.35 noted that 4 of the 16 
possible VH replacement products, that they found by searching human V-D junctions 
for matches to 3' ends of V gene segments, disagree with the gene order known so far, 
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but these were not proven VH replacements, and the authors did not find violation of the 
order in their serially-VH-replacing cell-line. 
If the hybrids were formed by RAG-mediated recombination at cryptic RSS, one 
would expect recombinations between VH segments from different families, just as with 
Type 1 VH replacements. The PCRs were carried out with VH Family 4 leader and Cμ, 
Cδ and Cγ primers and both parts of each hybrid were derived from VH4 segments, as 
would be expected in PCR artefact. However, if the sequences do represent in vivo 
recombined genes, the finding strongly favours homologous recombination since this is 
much more likely to occur between members of the same family. Another argument 
against RAG-mediated recombination is that it should have produced some hybrids 
shorter and others longer than normal VH segments by recombining at RSS at different 
positions in the two VH segments. No such products were found, though this could have 
been because they were non-functional and the cells bearing them were thus not 
amongst the selected IgD+IgM- cells. 
 If the hybrids of Wilson et al.36 were formed in vivo by RAG mediated 
recombination, then DNA double-strand breaks should be found at the proposed 
recombination junctions (from cleavage at cryptic RSS) as well as circular 
recombination products but all attempts to detect them failed or were inconclusive. The 
authors suggested that the Type 2 VH replacements they found might be the tip of the 
iceberg of all receptor revision because complete (i.e. Type 1) functional replacements 
of VH or JH would be invisible and non-functional rearrangements would be inactivated, 
allowing rearrangement on the other chromosome, or eliminated. 
Itoh et al.37 amplified IgM, IgG, and IgA heavy-chain sequences with Family 1 VH 
segments from synovial tissue samples from patients with rheumatoid arthritis. They too 
found hybrid sequences in some clones but no examples of the same hybrid with 
different mutations. Again, cryptic RSS were present in all the cross-over regions and 
again were always at the same position in the two recombining VH segments. As with 
the other investigators’ results, in half of their hybrids the 5' VH was from downstream 
of the original VH on existing genomic maps. The authors gave the following reasons 
why they thought that their results were genuine: (i) hybrid rearrangments were found in 
different tissues from the same patient and in different patients; (ii) they were found in 
PCRs from both cDNA and genomic DNA (using a consensus JH primer); (iii) RSS-like 
sequences were always found in the cross-over regions; (iv) rearrangements were 
always in-frame and coded for translatable proteins; (v) two different sets of related 
sequences showed members with different partial VH replacements to the same original 
VDJ either in the same heptamer-containing region or in different ones. Reasons (i), (ii) 
and (v) could all be accommodated by PCR artefact. Reason (iii) we have already 
discussed and will return to later. Reason (iv) could be explained by PCR hybridisation 
or homologous recombination, but would be less expected in a RAG-mediated process 
in which one might expect some diversification of the junctions. However, there is a 
better reason for believing that their results represented in vivo recombination. Though 
most of the receiving segments were of the same family as the incoming segments, there 
were two different hybrids in which a Family 1 segment was hybridised to the same 
original rearrangement with a Family 3 VH segment. Their VH primer was specific for 
Family 1 and they did not amplify any rearranged genes that started with a Family 3 VH 
segment, making the chances of generating artefactual hybrids with such a gene very 
small. Further support seemed to come from the following additional investigations. 
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Firstly, they looked for double strand breaks occurring at the cryptic RSS by blunt-
end ligation followed by PCR, using human bone marrow cells as positive controls and 
fibroblasts as negative controls. This showed clearly that double strand breaks (DSBs) 
occurred in the synovial tissue samples and the positive control but not in the fibroblasts 
and there were two distinct bands corresponding to cleavage at two VH heptamers, one 
of them the 3' cryptic RSS seen in most VH segments. Sequences of the PCR products 
were said to show that the breaks were at or within heptamers. RAG-mediated cleavage 
should be precisely at the edge of a heptamer. A break within one might suggest that the 
DNA had been chewed back but none of the examples of recombination in this paper 
showed any deletion. However, DSBs have since been found to occur even in 
unrearranged V gene segments40-42 which somewhat diminishes the significance of the 
finding, though the breaks tend to occur at RGYW·WRCY motifs. Secondly, Itoh et al. 
found evidence of RAG activity in several of their synovial tissue samples and the 
positive but not the fibroblast control. Taken together, these findings suggested that 
RAG-mediated recombination was occurring in the tissue but not whether it was Type 1 
or Type 2. Type 1 VH replacement with the 3' cryptic RSS would sometimes code for a 
functional product and the sequence would be identified as having secondary 
rearrangement only if a sequence with the original rearrangement were also cloned. 
Type 1 recombination with the more 5' cryptic RSS at which they saw cleavage would 
not be expected to have produced a functional antibody (see Fig. 1b. The product in this 
particular case would have been about 70 bp longer than the original). The authors 
considered the possibility that their hybrids could have been formed by RAG-mediated 
cleavage at cryptic RSS followed by homologous recombination. 
Single-cell PCR avoids the problem of hybrid product formation that can occur when 
DNA or RNA are extracted from many cells together. In order to determine whether VH 
replacement accompanies somatic hypermutation in the germinal centre Goossens et 
al.45 looked for hybrid VH segments in single-cell PCR products from 124 IgD-only and 
49 IgD-IgM- peripheral blood B cells and found no examples of Type 2 or Type 1. 
However, recently Lenze et al.38 have discovered very strong evidence in another way. 
They looked for Type 2 VH replacement in two human mucosa-associated lymphoid 
tissue (MALT) lymphomas. Using DNA from many cells and nested PCR of rearranged 
heavy-chain sequences, they found a major clone of related VDJs (with identical CDR3 
and JH) and a polyclonal background of many unrelated sequences in each tumour. In 
each case, the related set contained members with hybrid V segments. However, 23/26 
related sequences from three independent sets of PCRs from one tumour were VH3-
23(5')/VH3-07(3') hybrids. Only a single related sequence had the complete parent VH3-
07, but this contained several mutations that were not present in the hybrids but were in 
the region shared in common with them. This showed that it could not have been a PCR 
template for a hybrid artefact. The remaining two members of the clone had VH3-30 
hybridised to the same original VH3-07 rearrangement, and shared several mutations 
with the other hybrids that were not present in the sequence with the complete VH3-07. 
These findings alone are very good evidence that this type of VH replacement is a real in 
vivo event. Furthermore all the hybrids could be amplified using primers for the 
common CDR3, and the different CDR2s. In the other case, 49/53 related sequences had 
a complete VH4-59. The other four sequences were hybrids with three different VH 
segments. All the mutations in the complete VH were also present in the hybrids so PCR 
artefact cannot be excluded on these grounds. However, both alleles of VH4-61 were 
present in hybrids and therefore, if this occurred in vivo, there must have been exchange 
 8
between chromosomes. The other hybrid in this case was with VH4-04, which is 
downstream of VH4-59 and therefore should have been deleted in the initial VDJ 
recombination. The authors suggest that hybridisation with VH4-04 was the initial trans-
chromosomal event and that this was subsequently replaced by the VH4-61 allele 
upstream on the same chromosome. This is borne out by the mutation pattern. 
In both lymphomata, all the hybrids contained donor and acceptor VH segments from 
the same family. This agrees with our conclusion from the earlier papers that homology 
is involved in Type 2 recombination. In the first case, the likely point of exchange does 
not contain a cryptic RSS. In the second case, there are several potential cryptic RSS, 
one of which is shared by all hybridising genomic segments. Thus this paper provides 
strong evidence that Type 2 VH replacement is a real in vivo phenomenon, that it 
depends on sequence homology, and that, though cryptic RSS are frequently present in 
the cross-over region, this is not always the case. 
Cleavage at RSS by RAG proteins is affected by the DNA sequence in the coding 
flank46,47 and non-favourable sequences tend to receive a single-strand nick but not 
double-strand cleavage. Poor cryptic RSS away from the standard 3' position may 
therefore be more likely to be nicked. Though the RAG proteins direct DSBs to repair 
by NHEJ, these nicks are liable to engender repair by homologous recombination48 so, 
if there were any RAG activity, cryptic RSS could well be sites of origin of Type 2 
replacement by homologous recombination. However, most of the examples of Type 2 
replacement come from mutating cells in which most investigators believe RAG genes 
are not expressed. 
One of the hybrids of Itoh et al.37 shows no mutation before or after recombination. 
Recently further examples of VH-VH hybrids have been published49 in human immature 
B cells that have developed in NOD/SCID mice and show no somatic hypermutation. 
The five hybrid sequences in this paper are all between the same two family 4 VH 
segments, with one exchange region in two and another in the other three, and again 
cryptic RSS have been suggested in each region. One of these has a heptamer 
GACTGTT which seems very unlikely to act as an RSS since it contains neither CAC 
nor GTG. Though the authors experimented with producing PCR hybrids and concluded 
that the published sequences were probably not artefacts, there is nothing in the 
sequences themselves that can verify this. 
 
EXCEPTIONS OBSCURING THE DIFFERENCE BETWEEN TYPES 1 AND 2 
Though there is usually deletion and addition of nucleotides in Type 1 VH replacement 
and, in the common subtype, alteration of the VH-D junction, there are exceptions. One 
such was seen in one of the first cases reported50. Two sequences from a mouse B-cell 
lymphoma line were found to have different VH segments but to be identical from the 
beginnings of their VH-D junctions onwards so that this might appear to be a case of 
Type 2 VH replacement in which the cross-over was within the last 3 bp at the 3' ends of 
the VH segments. The authors, however, believed that the replacement had occurred by 
the mechanism that we now call Type 1. In the VH gene segments concerned, the 
distance between the 3' cryptic heptamer and the 3' end of the segments is 5 bp and there 
is a difference in the second base to the 3' of the heptamer. For the replacement to have 
occurred by the Type 1 mechanism described above, the new and old VH would have 
had to have been modified and joined in such a way that the VH was replaced 
seamlessly with neither frame-shift nor any change in the VH-D junction. Later the same 
authors19 published the same replacement and a replacement of yet another complete VH 
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to the same original, again with no frame-shift nor change in the junction. The finding 
of two such replacements to the same substrate is very unlikely unless either they were 
Type 2 or some other mechanism was operating to ensure perfect match. 
It is now known that there is another mechanism that can explain their observations. 
In mice, particularly fetal and neonatal ones51,52, and in fetal and neonatal humans53, 
pairs of coding ends to be joined in V(D)J rearrangement may be overlapped and 
spliced at regions of sequence identity as little as 1 - 5 bp in length. This is more 
frequent in the absence of TdT (refs in Ref 52) or Ku86, which also seems to be involved 
in the addition of extra nucleotides54. In the light of knowledge of the place of non-
homologous recombination in V(D)J rearrangement, the explanation is clear. After non-
templated addition of nucleotides to the coding ends, the formation of the join by the 
matching of ‘microhomologies’ in these sequences is not apparent because these 
nucleotides are not present in the genomic sequences. However, when there is no 
addition of nucleotides, the matching of micohomologies is apparent because these 
sequences belong to the genomic segments. After cleavage at the internal heptamer in 
the VH portion of a rearranged VHDJH, the stump of the old VH is effectively the new 5' 
end of the D that is to be joined to the new VH so the substrate is there for the type of 
recombination described above. This mechanism could not account for most of the 
reported sequences that appear to be Type 2 VH replacement because cleavage of the 
two VH gene segments at equivalent positions would leave no homologous ends to 
overlap. However, it has also been reported that, in transfected V(D)J recombination 
substrates in Ku86 deficient mouse cell lines, hybrid joints are abundant, and that the 
majority of them have no nucleotide excision from either of the ends and no nucleotide 
addition55. 
 
THE TIMING OF EVENTS 
Most of the examples proposed as Type 2 VH replacement have been in cells 
undergoing somatic hypermutation (SHM). Therefore the contention that cryptic RSS 
are involved requires that RAG proteins are re-expressed in mature, mutating cells 
(unless there is another, unknown, protein that recognises RSS). Though Itoh et al.37 
found RAG mRNA in several of their synovial tissue samples, they did not demonstrate 
that it was expressed as protein or that it came from mutating cells, and Zhang et al.35 
concluded that Type 1 VH replacement does not occur later than the immature B cell 
stage. 
AID (activation-induced cytidine deaminase) is essential not only for SHM but also 
for immunoglobulin gene conversion and class-switching, and the initiating event in 
each case is believed to be the deamination of deoxycytosine to uracil56. Gene 
conversion is a non-reciprocal form of homologous recombination in which a section of 
a gene is replaced by copying from another without alteration of the template gene. This 
is the primary method of producing antibody diversity in birds and several investigated 
mammals but not primates and rodents57. Though gene conversion has not been 
observed in rearranged human VH segments, it has recently been shown that the 
expression of AID in human B cells is associated with the appearance of double-strand 
breaks with single-stranded protruding ends which are repaired by homologous 
recombination43. Therefore, if Type 2 VH replacement occurs by homologous 
recombination it could well appear in mutating cells and the mechanism might be gene 
conversion rather than reciprocal exchange. 
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By homologous recombination, one double- or single-stranded break in the 
rearranged V might be repaired by crossing over of strands, using as the template an 
unrearranged V segment on the same chromosome, the sister chromatid (in G2 phase of 
the cell cycle), or even on the homologous chromosome, in which case a downstream V 
segment might be used. Such a repair would not generate a deletion circle (as shown in 
Fig 2b) and this could be the reason why Wilson et al. failed to detect circular 
recombination products, though it is not the only possibility36. 
There are however two problems with this: 1. either the length of the repair must 
always be so long that only one cross-over point is within the VH or there must be 
unrecognised cases in which both ends of the piece of new V-segment are within the old 
V segment, as in other species; 2. how to explain the fact that cryptic RSS are found in 
the cross-over region in almost all cases if they are not involved. We have therefore re-
examined the published examples of Type 2 VH replacement for AID recognition sites 
in the V-V cross-over regions that could explain replacement by AID-initiated 
homologous recombination, and discovered answers to both problems. 
It has recently been shown58 that AID prefers dA or dG at the –1 position to the 
targeted cytosine, and dA or dT at the –2 position. This gives WRC - reverse 
complement GYW - which corresponds to part of the previously identified 
RGYW/RGY hypermutation hotspot motif (reverse complement WRCY/RCY). Of the 
different VH-VH junctional regions shown by Wilson et al.36 5/9 have the complete 
WRCY·RGYW motif in the hybrid, or in the region of the germline sequence where 
hybridization occurred, and all the others contain WRC·GYW or RCY·RGW. Likewise, 
the sequences of Itoh et al.37 and Lenze et al.38 have AID target motifs in the exchange 
regions. Furthermore, those of Itoh et al.37 include four examples suggestive of gene 
conversion, i.e. an internal section of the VH resembles a different germline segment 
while both ends resemble the parent rearrangement. There is insufficient room for a 
detailed analysis here, and we shall discuss it more fully elsewhere, but give a brief 
description here of one of these examples. Two rearranged genes with the same HCDR3 
were presented (their Figure 5B), one (ST1R G1) resembling a VH1-02/VH3-09 hybrid 
and the other (ST1R G2) a VH1-69/VH3-09 hybrid, which we shall refer to as G1 and 
G2. On closer inspection, both sequences resemble VH1-69 at their 5' ends and the 
section of G1 that exclusively matches VH1-02 is confined to nucleotides (nt) 148-222. 
G1 therefore seems to have resulted from a substitution of a section of VH1-02 into the 
G2 rearrangement followed by further hypermutation. The matching parts of both 
sequences contain several mutations not present in the other, which seems to exclude 
the possibility of PCR artefact. This and the other three examples are therefore 
consistent with gene conversion. 
RGYW motifs are common in VH gene segments and the hybrid sequences of Kolar 
& Capra49 have the motif in their exchange regions though the hybrids are from 
immature cells that would not be expressing AID. However, PCR artefact cannot be 
ruled out for these sequences, and could have occurred from template DNA with double 
strand breaks at RGYW motifs. 
 
CONCLUDING REMARKS 
There are many examples of recombination of VH gene segments into previously 
existing VDJ sequences by a process that we have named Type 1 VH replacement. 
Before its recent decisive investigation35, this was already clearly a RAG-mediated 
process involving the RSS of the incoming VH and a cryptic RSS within the 3' end of 
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the originally recombined VH segment gene. It occurs in immature B cells in which the 
RAG genes are normally active. Evidence has also been presented36-38,49 for VH 
replacement by another mechanism, that we have called Type 2, of which most 
examples are from actively mutating B cells. It resembles homologous recombination 
between two VH segments, and does not bear the hallmarks of NHEJ. It has not gained 
acceptance so far because similar hybrid sequences can be produced as PCR artefacts 
and it was believed to be mediated by RSS and RAG proteins, though RAG genes 
usually are suppressed in hypermutating cells. Those who would dismiss the evidence 
on the grounds that a single specific search45 has failed to find this type of VH 
replacement should remember that Type 1 VH replacement was also previously 
dismissed on the basis of failure to find it in a specific search17. Detailed examination of 
the sequences shows that (a) some of them are extremely unlikely to have been 
produced by PCR artefact (b) AID target motifs can be found in the regions of exchange 
between the VH segments (suggesting that the finding of cryptic RSS may have been a 
red herring), and (c) in some cases the region replaced does not reach either end of the 
original VH. Therefore, though hybrids undoubtedly occur as an artefact during PCR, 
and may account for some of the published examples, we believe that Type 2 VH 
replacement probably does occur in vivo and results from AID-mediated homologous 
recombination. Whether the exchange is reciprocal homologous recombination or gene 
conversion can only be determined experimentally but, in view of the results from other 
species, the most reasonable model is gene conversion with replacement often including 
the 5' end of the VH. 
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Figure legends 
 
Figure 1.   Type 1 VH replacement. (a) Usual subtype: recombination occurs after 
cleavage at the conventional RSS of a new (upstream) VH and at the 3' cryptic RSS in 
the VH portion of the recombined VH-D-JH. (b) Cleavage occurs at the conventional RSS 
of the incoming VH but at an upstream cryptic RSS of the VH of the VDJ. (c) Cleavage 
occurs at cryptic RSS in opposite directions and different positions in the two VH genes. 
In this and all other figures, the conventional RSS are indicated by filled triangles and 
cryptic RSS by open triangles. Small arrows indicate cleavage positions and deletion 
products are omitted. ‘~’ indicates the typical random small deletions from either or 
both coding ends and added P and N bases. 
 
Figure 2.   Comparison of Types 1 and 2 VH replacement. (a) Detail of the usual form 
of Type 1 involving the conventional RSS of the incoming VH and the 3' cryptic RSS in 
the VH portion of the pre-existing VH-D-JH. Diagram conventions are as in Fig. 1. Just 
as in normal V(D)J recombination, the new junction in the VDJ is a coding-to-coding 
junction and the deletion product has a signal-to-signal junction. (b) A Type 2 VH 
replacement scheme to explain the published hybrid sequences by the investigators’ 
hypothesis of RAG-mediated double-strand cleavage at cryptic RSS and rejoining 
without end modification. Reaction products shown are a VHDJH with the hybrid VH of 
the kind published and the deduced circular deletion product, both with cryptic RSS 
signal-to-coding junctions. Alternative mechanisms are homologous recombination 
following RAG-mediated single-strand nicking at a cryptic RSS and our preferred 
hypothesis of AID-initiated homologous recombination unrelated to RAG or cryptic 
RSS. Homologous repair in these cases need not involve any deletion. 
 
Figure 3.   Construction of a sequence resembling Type 2 VH replacement by PCR 
artefact. The N and P bases between VH and D and between D and JH are omitted for 
simplicity. (a) Copies of cDNA of two rearranged immunoglobulin heavy-chain genes 
occurring at an early stage in the same reaction mixture. ‘p’ is a PCR product made with 
a specific family VH leader primer and a specific constant-region primer. ‘q’ is another 
rearrangement with a different D and JH. The VH differs from that of p at various points 
indicated by the pink spots in p and blue spots in q. q may be another PCR product with 
the same leader sequence, or it may be a cDNA template with a different leader that 
would not have been amplified with the primers in use. (b) During one of the PCR 
cycles, ‘n’, a copy of p, is incomplete when melting occurs. (c) In the next cycle n 
anneals with q at a point at which q has the same sequence as p. A polymerase molecule 
attaches and copying continues, giving a product (the extended ‘n’) that has the leader 
and 5' end of the VH the same as in p but the 3' end of the VH and the VDJ junction the 
same as q. This new molecule will now be amplified in all following cycles. 
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